JESSICA BATTAGLIA: Open Payments
NPI 1699425702 · RAEFORD, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,398 in 53 payments from 14 companies in 2025. Trend: 2023 $479 · 2024 $860 · 2025 $1,398
Food & beverage: $1,398
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $487 |
| Lilly USA, LLC | 12 | $364 |
| AstraZeneca Pharmaceuticals LP | 5 | $176 |
| GlaxoSmithKline, LLC. | 4 | $61 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $52 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $50 |
| Radius Health, Inc. | 2 | $48 |
| Corcept Therapeutics | 2 | $41 |
| Amgen Inc. | 1 | $25 |
| Medtronic, Inc. | 1 | $25 |
Products named: ZEPBOUND, Ozempic, Wegovy, FARXIGA, JARDIANCE, TRELEGY ELLIPTA, MOUNJARO, Kerendia.
Industry payments across NC — which companies pay providers there.
